0
Deep & Emerging Tech·September 8, 2026·1 min read

Insilico's Lung Drug Reverses Aging Markers in Study

Share

An AI-discovered lung drug showing reversal of biological aging markers is a proof point for AI-native pipelines in drug discovery, not just tooling around the edges. Biotech operators should assume regulators and partners will increasingly ask whether you can generate — and validate — similar AI-first candidates, not just incremental screens.

Deep & Emerging Tech

Nvidia CEO Jensen Huang says a forgotten 1950s European alliance secretly secured Taiwan’s chip empire — decades later, an island hardly bigger than Maryland dominates 90% of the advanced chip market

Huang’s framing of Taiwan’s chip dominance as the product of decades-long alliances and industrial planning is a reminder that AI capacity is downstream of geopolitical compounding, not quarterly vendor deals. If your roadmap assumes unconstrained advanced-node supply, you’re making a political bet as much as a technical one.